The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vaxart Inc. shares valued at $16,100 were purchased by Ahmad Fuad on Jun 22. At $3.22 per share, Ahmad Fuad acquired 5,000 shares. The insider’s holdings grew to 5,000 shares worth approximately $19550.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Also, Echerd Margaret sold 3,602 shares, netting a total of over 28,816 in proceeds. Following the sale of shares at $8.00 each, the insider now holds 0 shares.
Before that, Echerd Margaret had sold 1,801 shares from its account. In a trade valued at $16,389, the SVP, Principal Accntng Officer traded Vaxart Inc. shares for $9.10 each. Upon closing the transaction, the insider’s holdings decreased to 1,801 shares, worth approximately $0.0.
Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in early November. As of June 29, 2021, B. Riley Securities has decreased its “Buy” rating to a “Neutral” for VXRT. Earlier on June 24, 2021, Jefferies initiated its rating. Their recommendation was “a Buy” for VXRT stock.
Analyzing VXRT’s Price Performance
On Thursday, Vaxart Inc. [NASDAQ: VXRT] rose 2.62% to $3.91. The stock’s lowest price that day was $3.77, but it reached a high of $3.98 in the same session. During the last five days, there has been a surge of approximately 5.68%. Over the course of the year, Vaxart Inc. shares have dropped approximately -37.64%. Shares of the company reached a 52-week high of $6.80 on 01/05/22 and a 52-week low of $2.49 on 05/12/22. A 50-day SMA is recorded $3.69, while a 200-day SMA reached $4.97. Nevertheless, trading volume fell to 2.53 million shares from 1.7 million shares the previous day.
Support And Resistance Levels for Vaxart Inc. (VXRT)
According to the 24-hour chart, there is a support level at 3.79, which, if violated, would cause prices to drop to 3.68. In the upper region, resistance lies at 4.00. The next price resistance is at 4.10. RSI (Relative Strength Index) is 52.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.00, which suggests the price will decrease in the coming days. Percent R is at 58.82%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Vaxart Inc. subject to short interest?
Stocks of Vaxart Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -1.1 million shares to 22.13 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 23.23 million shares. A decline of -4.97% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.18 of the overall float, the days-to-cover ratio (short ratio) decline to 8.18.
Which companies own the most shares of Vaxart Inc. (VXRT)?
According to SSgA Funds Management, Inc. filings, the company currently owns 13,860,974 shares, which is about 10.96% of the total VXRT shares outstanding. The investor’s shares have appreciated by 2,673,332 from its previous 13-F filing of 11187642.0 shares. With the completion of the sale transaction, BlackRock Fund Advisors’s stake is now worth $26,940,764. The Vanguard Group, Inc. acquire a 1.93% interest valued at $20.22 million while Geode Capital Management LLC purchased a 140,341 stake. A total of -534,283 shares of Vaxart Inc. were bought by D. E. Shaw & Co. LP during the quarter, and 1,066,667 were bought by Morgan Stanley & Co. LLC. In its current portfolio, Northern Trust Investments, Inc. holds 1,196,224 shares valued at $4.19 million.
In terms of Vaxart Inc. share price expectations, FactSet research, analysts set an average price target of $9.75 in the next 12 months, up nearly 175.59% from the previous closing price of $3.81. Analysts anticipate Vaxart Inc. stock to reach $12.00 by 2022, with the lowest price target being $6.00. In spite of this, 4 analysts ranked Vaxart Inc. stock as an Overweight at the end of 2022. On June 11, 2021, Piper Sandler assigned a price target of “an Overweight” to the stock and initiated coverage with a $18.